Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 106.73M | 95.13M | 83.72M | 74.26M | 66.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 106.73M | 95.13M | 83.72M | 74.26M | 66.40M |
| Cost of Revenue | 49.22M | 46.26M | 42.91M | 39.80M | 37.54M |
| Gross Profit | 57.51M | 48.86M | 40.81M | 34.46M | 28.86M |
| SG&A Expenses | 178.75M | 164.12M | 165.19M | 146.28M | 129.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 250.25M | 229.87M | 227.33M | 203.71M | 183.23M |
| Operating Income | -143.52M | -134.74M | -143.61M | -129.45M | -116.83M |
| Income Before Tax | -149.56M | -131.32M | -143.68M | -131.29M | -119.16M |
| Income Tax Expenses | 311.00K | 294.00K | 204.00K | 187.00K | 161.00K |
| Earnings from Continuing Operations | -149.87 | -131.61 | -143.89 | -131.48 | -119.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -942.00K | -692.00K | -439.00K |
| Net Income | -149.87M | -131.61M | -144.83M | -132.17M | -119.76M |
| EBIT | -143.52M | -134.74M | -143.61M | -129.45M | -116.83M |
| EBITDA | -134.18M | -126.03M | -135.39M | -121.32M | -109.20M |
| EPS Basic | -2.67 | -2.42 | -4.00 | -4.64 | -5.19 |
| Normalized Basic EPS | -1.60 | -1.51 | -2.43 | -2.72 | -2.96 |
| EPS Diluted | -2.67 | -2.42 | -4.00 | -4.64 | -5.19 |
| Normalized Diluted EPS | -1.60 | -1.51 | -2.43 | -2.72 | -2.96 |
| Average Basic Shares Outstanding | 224.19M | 216.93M | 183.11M | 147.15M | 115.66M |
| Average Diluted Shares Outstanding | 224.19M | 216.93M | 183.11M | 147.15M | 115.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |